AIG
HUMA icon

American International Group’s Humacyte HUMA Stock Holding History

American International Group’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-30,180
Closed -$93.9K – 1242
2024
Q1 		$93.9K Sell
30,180
-259
-0.9% -$871 ﹤0.01% 2555
2023
Q4 		$86.4K Sell
30,439
-123
-0.4% -$316 ﹤0.01% 2637
2023
Q3 		$89.5K Buy
30,562
+1,086
+4% +$3.59K ﹤0.01% 2566
2023
Q2 		$84.3K Buy
29,476
+1,105
+4% +$3.98K ﹤0.01% 2684
2023
Q1 		$87.7K Buy
28,371
+565
+2% +$1.61K ﹤0.01% 2523
2022
Q4 		$58.7K Buy
27,806
+19,428
+232% +$59K ﹤0.01% 2699
2022
Q3 		$27K Buy
8,378
+118
+1% +$453 ﹤0.01% 2953
2022
Q2 		$27K Buy
+8,260
New +$45.9K ﹤0.01% 2986

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

American International Group's HUMA Position: Q2 2024 in Review

American International Group sold out of Humacyte (HUMA) in Q2 2024, closing a stake of 30,180 shares — an estimated $93.9K sold.

American International Group first reported a position in HUMA in Q2 2022 and held it in 8 quarters. The position peaked at $93.9K in Q1 2024. 123 funds tracked by Wall St. Rank hold HUMA as of Q2 2024.

  • American International Group reported no remaining Humacyte position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 30,180 Humacyte shares in Q2 2024, an estimated $93.9K.
  • American International Group first reported a position in Humacyte in Q2 2022 and held it in 8 quarters.
  • American International Group's Humacyte position peaked at $93.9K in Q1 2024.
  • 123 funds tracked by Wall St. Rank held Humacyte as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.